Researchers in Brazil have discovered that hashish oil might be an efficient therapy for sufferers with fibromyalgia, in keeping with the outcomes of a medical trial accomplished not too long ago. An abstract of the examine, “Ingestion of THC-rich cannabis oil in people with fibromyalgia: A randomized, double-blind, placebo-controlled clinical trial,” was printed final week within the journal Pain Medicine.
To conduct the examine, researchers examined the effectiveness of a plant-derived hashish oil on 17 ladies with fibromyalgia (FM), a continual ache syndrome characterised by widespread musculoskeletal ache and fatigue. The sufferers had been handled over a interval of eight weeks with a hashish oil wealthy in THC. The preliminary dose was one drop per day, with subsequent dosage will increase in keeping with signs. The imply dose for these within the hashish group was 3.6 drops per day, equating to a complete of 4.Four milligrams of THC and 0.08 milligrams of CBD per dose.
Patients had been separated into two teams, one among which obtained the hashish oil, whereas the members of the management group obtained a placebo. The Fibromyalgia Impact Questionnaire (FIQ) was administered at pre- and publish intervention moments and in 5 visits over eight weeks. The researchers reported that “the impact of the intervention on quality of life in the cannabis group participants was evident, resulting in reports of well-being and more energy for activities of daily living. Pain attacks were also reduced.”
First Gold-Standard Study
“To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil – a THC-rich whole plant extract – on symptoms and on quality of life of people with fibromyalgia,” the investigators wrote. “We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients, and we suggest that this therapy could be included as an herbal medicine option for the treatment of this condition in the Brazilian public health system.”
Because of the impression that fibromyalgia can have on the well being of sufferers and the necessity for efficient and reasonably priced medicines to deal with them, the researchers really helpful additional analysis to check hashish as a therapy for the situation.
“Considering the far-reaching damage caused by FM and the effect it can have on individuals, their families, communities, and the public health system, it seems necessary to study alternative, low-cost, and well-tolerated therapies that help patients to regain their well-being and quality of life,” the wrote. “The present study aims to evaluate the impact that cannabis oil—a THC-rich whole plant extract—can have on symptoms and quality of life of individuals afflicted by FM.”
Paul Armentano, the deputy director of the National Organization for the Reform of Marijuana Laws (NORML), commented on the analysis in a press release from the group on Friday.
“The demonstration of safety and efficacy in this gold-standard model is significant,” Armentano said. “Millions of Americans suffer with FM – a condition that tends to be poorly controlled by standard medicines. These clinical findings indicate that for many of these patients, plant-derived cannabis preparations may be a safe and effective alternative.”